Does bevacizumab ( Avastin ) eye drop inhibit corneal neovascularization?
Bevacizumab eye drops seem to inhibit corneal neovascularization without obvious corneal epithelial side-effects.
Our study suggests not only that rCBV measurements correlate well with time to progression or death, but also that the findings can be replicated across institutions, which supports the application of rCBV as an adjunct to pathology in predicting glioma biology.